Funding for the Cancer Research UK Cambridge Institute

The total funding of the Cancer Research UK Cambridge Institute for 2018 is £45 m. The major source of this funding is Cancer Research UK core funding of £22.9 m and additional research grant funding of £4.9 m. The infrastructure of the CRUK Cambridge Institute is funded by HEFCE generated income of £2.9 m.


    CRUK Cambridge Institute Funding 2018

 


The balance of the Institute’s funding is received from a number of additional sources as follows:

Aarhus University
Academy of Medical Sciences
Addenbrooke’s Charitable Trust
Agilent Technologies Inc.
American Association for Cancer Research
Anticancer Fund
Aprea AB
AstraZeneca
BBSRC
Bicycle Therapeutics Ltd
Breast Cancer Research Foundation
British Heart Foundation
Cambridge University Hospitals NHS Foundation Trust
CERN
Cold Spring Harbor Laboratory
Curesearch
EMBO
EPSRC
European Commission
European Research Council
F Hoffman la Roche Ltd
Genentech
General Sir John Monash Foundation
Genetics Society
GSK
IMI JU
Institut de Recherches Servier
JISC
John Hopkins University
Mathile Family Foundation
Medimmune
MRC
National Institutes of Health
National Physical Laboratory
Netherlands Organisation for Scientific Research
Norwegian University of Science and Health
Pancreatic Cancer UK
Pathological Society of Great Britain and Ireland
Pew Charitable Trusts
Prexion Corporation
Rising Tide
Rosetress Trust
Royal College of Surgeons
Royal Society
Silicon Valley Community Foundation
Sloan Kettering Institute for Cancer Research
Sohn Foundation
St Jude Children’s Research Hospital
Susan G Komen
US Army
US Department of Defense CDMRP
Vall d’Hebron Institute of Oncology
Wellcome Trust

We are immensely grateful to all our sponsors.